NAFDAC blacklists Onifam laboratories over regulatory breaches
According to the statement, the alleged infractions include regulatory misrepresentation, misuse of NAFDAC approvals and certificates, improper registration and transfer of pharmaceutical products, and actions aimed at circumventing established regulatory processes.
The agency reaffirmed its commitment to ensuring compliance with regulatory standards and urged stakeholders in the pharmaceutical sector to adhere strictly to relevant laws and guidelines.
Mojisola Adeyeye, said investigations by the agency uncovered multiple violations of regulatory requirements governing the pharmaceutical sector.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
